PMA P030032S012

Device
HYLAFORM (HYLAN B GEL); PREVELLE SILK
Applicant
Genzyme Biosurgery
PMA number
P030032
Supplement
S012
Product code
LMH
Decision date
2011-07-18
Generic name
Implant, dermal, for aesthetic use
Approval order statement
APPROVAL FOR CHANGES IN THE METHODS AND SPECIFICATIONS FOR TESTING THE PREVELLE SILK FINAL PRODUCT (I.E., 1) CHANGING THE AVERAGE EXTRUSION FORCE SPECIFICATIONFROM LESS THAN 80N TO AN AVERAGE OF AVERAGE EXTRUSION FORCE SPECIFICATION OF LESS THAN 40N, 2) CHANGING THE MAXIMUM PEAK EXTRUSION FORCE SPECIFICATION OF LESS THAN 100N TO AN AVERAGE OF MAXIMUM PEAK EXTRUSION FORCE" SPECIFICATION OF LESS THAN 50N AND 3) CHANGING THE METHOD OF DETERMINING THE MAXIMUM PEAK EXTRUSION FORCE SPECIFICATION FROM THE HIGHEST SINGLE VALUE OBSERVED IN 10 SAMPLES TO AN AVERAGE OF THE MAXIMUM PEAK EXTRUSION FORCE TEST RESULTS OBSERVED IN 25 SAMPLES).

Current openFDA PMA Record#

Device
HYLAFORM (HYLAN B GEL); PREVELLE SILK
Applicant
Genzyme Biosurgery
PMA number
P030032
Supplement
S012
Product code
LMH
Generic name
Implant, dermal, for aesthetic use
Decision date
2011-07-18
Decision code
APPR
Date received
2011-05-27
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
APPROVAL FOR CHANGES IN THE METHODS AND SPECIFICATIONS FOR TESTING THE PREVELLE SILK FINAL PRODUCT (I.E., 1) CHANGING THE AVERAGE EXTRUSION FORCE SPECIFICATIONFROM LESS THAN 80N TO AN AVERAGE OF AVERAGE EXTRUSION FORCE SPECIFICATION OF LESS THAN 40N, 2) CHANGING THE MAXIMUM PEAK EXTRUSION FORCE SPECIFICATION OF LESS THAN 100N TO AN AVERAGE OF MAXIMUM PEAK EXTRUSION FORCE" SPECIFICATION OF LESS THAN 50N AND 3) CHANGING THE METHOD OF DETERMINING THE MAXIMUM PEAK EXTRUSION FORCE SPECIFICATION FROM THE HIGHEST SINGLE VALUE OBSERVED IN 10 SAMPLES TO AN AVERAGE OF THE MAXIMUM PEAK EXTRUSION FORCE TEST RESULTS OBSERVED IN 25 SAMPLES).